IGM Biosciences Gross Profit vs. Cash Per Share
| IGMS Stock | USD 8.22 1.03 11.14% |
Gross Profit | First Reported 2010-12-31 | Previous Quarter -6.1 M | Current Value -6.5 M | Quarterly Volatility 5.4 M |
For IGM Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of IGM Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well IGM Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between IGM Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of IGM Biosciences over time as well as its relative position and ranking within its peers.
IGM |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IGM Biosciences. If investors know IGM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IGM Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.21) | Revenue Per Share 0.048 | Quarterly Revenue Growth 0.014 | Return On Assets (0.37) | Return On Equity (1.32) |
The market value of IGM Biosciences is measured differently than its book value, which is the value of IGM that is recorded on the company's balance sheet. Investors also form their own opinion of IGM Biosciences' value that differs from its market value or its book value, called intrinsic value, which is IGM Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IGM Biosciences' market value can be influenced by many factors that don't directly affect IGM Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IGM Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if IGM Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IGM Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
IGM Biosciences Cash Per Share vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining IGM Biosciences's current stock value. Our valuation model uses many indicators to compare IGM Biosciences value to that of its competitors to determine the firm's financial worth. IGM Biosciences is rated third overall in gross profit category among its peers. It also is rated third overall in cash per share category among its peers . The ratio of Gross Profit to Cash Per Share for IGM Biosciences is about 97,626 . At this time, IGM Biosciences' Gross Profit is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value IGM Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.IGM Cash Per Share vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
IGM Biosciences |
| = | 1.07 M |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
IGM Biosciences |
| = | 10.95 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
IGM Cash Per Share Comparison
IGM Biosciences is currently under evaluation in cash per share category among its peers.
IGM Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in IGM Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, IGM Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of IGM Biosciences' change in net profit over the period of time. It can combine multiple indicators of IGM Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 151 K | 158.6 K | |
| Operating Income | -263.5 M | -250.3 M | |
| Net Loss | -238.3 M | -226.4 M | |
| Income Before Tax | -245.7 M | -233.5 M | |
| Non Operating Income Net Other | 182.8 K | 173.7 K | |
| Total Other Income Expense Net | 17.7 M | 18.6 M | |
| Net Loss | -199 M | -189 M | |
| Net Loss | -246.4 M | -234.1 M | |
| Income Tax Expense | 678 K | 711.9 K | |
| Net Interest Income | 16.8 M | 17.7 M | |
| Interest Income | 16.8 M | 17.7 M | |
| Change To Netincome | 62.1 M | 65.2 M | |
| Net Loss | (4.71) | (4.95) | |
| Income Quality | 0.78 | 0.83 | |
| Net Income Per E B T | 1.00 | 0.78 |
IGM Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on IGM Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of IGM Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the IGM Biosciences' important profitability drivers and their relationship over time.
Use IGM Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IGM Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IGM Biosciences will appreciate offsetting losses from the drop in the long position's value.IGM Biosciences Pair Trading
IGM Biosciences Pair Trading Analysis
The ability to find closely correlated positions to IGM Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IGM Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IGM Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling IGM Biosciences to buy it.
The correlation of IGM Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IGM Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if IGM Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for IGM Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your IGM Biosciences position
In addition to having IGM Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Sovereign ETFs Thematic Idea Now
Broad Sovereign ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Sovereign ETFs theme has 14 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Sovereign ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for IGM Stock Analysis
When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.